Drug Patent Challenge Report profiles companies that successfully challenged pharmaceutical drugs
DrugPatentWatch.com introduces Drug Patent Challenge Report
DrugPatentWatch.com introduces Drug Patent Challenge Report
DrugPatentWatch.com announces new Orphan Drug Exclusivity report
Orphan Drug Exclusivity profiles FDA-approved Orphan Drugs Read Post »
DrugPatentWatch.com adds new search functionality
Leading drug inventors responsible for drugs approved over the past ten years profiled in new DrugPatentWatch report
Who are the leading drug innovators, and where do they live? Read Post »
The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies
In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s
DCbiotech is a high-level networking group based in Washington DC. The objective is to bring together individuals working in, or
Introducing DCbiotech — High-level networking in the nation's capital Read Post »
A recent UMD study has found that VCs pay little attention ot the content of business plans.This is not much
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products
I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th
Biotechnology Certificate Program at JHU's Carey School of Business Read Post »